Status:
COMPLETED
A Study Aimed at Assessing the Pharmacokinetic Properties of RGB-10 and Forsteo
Lead Sponsor:
Gedeon Richter Plc.
Conditions:
Healthy
Eligibility:
FEMALE
18-55 years
Phase:
PHASE1
Brief Summary
Pharmacokinetic properties, safety and tolerability of RGB-10 and Forsteo will be compared in healthy female volunteers.
Eligibility Criteria
Inclusion
- Healthy adult female subjects
- 18-55 years of age (inclusive)
- BMI must be between 18.5 and 27 kg/m2 (inclusive)
Exclusion
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02223416
Last Update
March 18 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Celerion (UK)
Belfast, United Kingdom